In an interview with PharmaShots, Apellis' Chief Medical Officer, Federico Grossi shares his views on the data presented at ARVO 2021. The studies support AI analytics as a tool to distinctly measure disease activity well as the therapeutic effect in GA.Shots:Apellis presented five oral presentations from an AI collaboration with the Ophthalmic Imaging Analysis (OPTIMA)…
